Walker & Dunlop Inc.

11/18/2024 | Press release | Distributed by Public on 11/18/2024 16:01

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Groman Daniel J
2. Date of Event Requiring Statement (Month/Day/Year)
2024-11-08
3. Issuer Name and Ticker or Trading Symbol
Walker & Dunlop, Inc. [WD]
(Last) (First) (Middle)
C/O WALKER & DUNLOP, INC. , 7272 WISCONSIN AVENUE, SUITE 1300
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
EVP, GC, Secretary & CCO /
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
BETHESDA MD 20814
6. Individual or Join/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Date Exercisable and Expiration Date 3. Title and Amount of Securities Underlying Derivative Security 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 6. Nature of Indirect Beneficial Ownership
Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Groman Daniel J
C/O WALKER & DUNLOP, INC.
7272 WISCONSIN AVENUE, SUITE 1300
BETHESDA, MD20814


EVP, GC, Secretary & CCO

Signatures

/s/ Daniel J. Groman 2024-11-18
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 4,360 shares of restricted stock, which vest in accordance with the terms of the applicable award.
(2) The deferred stock units are fully vested and will be settled in shares of the Issuer's common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Management Deferred Stock Unit Purchase Plan, as amended (the "Plan"), or (ii) as otherwise provided by the Plan.
(3) Each deferred stock unit represents the right to receive one share of common stock of the Issuer.
(4) The restricted stock units will be settled in shares of the Issuer's common stock on a date selected by the reporting person pursuant to the Plan, subject to vesting acceleration pursuant to the Plan.
(5) Each restricted stock unit represents the right to receive one share of common stock of the Issuer.
(6) The dividend equivalent rights accrued on restricted stock units held by the reporting person and will vest proportionately with the restricted stock units to which they relate.
(7) Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.